Denovo Biopharma's Liafensine Shows Promise in Phase 2b Trial for Treatment-Resistant Depression

Denovo Biopharma LLC (Denovo), a pioneer in applying precision medicine to the development of innovative drugs, today announced positive results for its bi...

April 09, 2024 | Tuesday | News
Nucleai and GoPath Diagnostics Partner to Advance Digital Pathology with AI Integration

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...

April 08, 2024 | Monday | News
Johnson & Johnson Sounds Alarm on TRC Capital Investment's Below-Market Mini-Tender Offer for Company Shares

Johnson & Johnson announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to...

April 05, 2024 | Friday | News
Johnson & Johnson Expands Commitment to Advance Health Equity

Johnson & Johnson announced  that it is collaborating with more than 100 community-led health organizations supporting historically marginalized c...

April 04, 2024 | Thursday | News
Biological Dynamics Expands Adoption of ExoVerita™ Pro Under Early Access Program

“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...

April 03, 2024 | Wednesday | News
Agilent Technologies and UC San Diego to Establish Center of Excellence in Cellular Intelligence

Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...

April 03, 2024 | Wednesday | News
Voydeya Approved as Add-On Therapy for Rare PNH Treatment in the US

Voydeya (danicopan) has been granted approval in the United States as an add-on therapy for the treatment of extravascular haemolysis (EVH) in adults diagn...

April 02, 2024 | Tuesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
Laborie Medical Technologies Corp. Invests in iO Urology's Revolutionary At-Home Uroflow Device for BPH Management

Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie) announced its investment in iO Urology, a vent...

April 01, 2024 | Monday | News
Exact Sciences and Mayo Clinic Report Promising Data on Non-Endoscopic Esophageal Cancer Screening Test

  Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, in collaboration with Mayo Clinic Compr...

March 28, 2024 | Thursday | News
Exothera Expands World-First Continuous-Batch RNA Manufacturing Solution to North America to Accelerate RNA Therapies

Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...

March 27, 2024 | Wednesday | News
Nucleus Genomics Launches to Bring Whole-Genome Sequencing to the Public

    Nucleus Genomics, a pioneering genetic testing and analysis company, announced the debut of its DNA analysis product, marking a significant...

March 26, 2024 | Tuesday | News
New Treatment Option for Prostate Cancer Shows Successful Outcomes

    Prostate cancer treatment traditionally involves radiation or surgery, both carrying risks of adverse effects like urinary incontinence and...

March 25, 2024 | Monday | News
Within3 and Array Announce Partnership to Set New Standards in Life Science Stakeholder Engagement

    Within3 and Array have announced a strategic partnership integrating synchronous and asynchronous insights management. This partnership is ...

March 20, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close